Donate

News

Latest news

Multiple Myeloma Queenstown Summit

June 29, 2022, ,

Multiple Myeloma Research Review

May 23, 2022, , ,

Multiple Myeloma CEO, Dr Ken Romeril, on The AM Show this morning, calling for a release of the independent report on Pharmac

May 11, 2022

DOCTOR CALLS ON MINISTER LITTLE TO RELEASE ‘BURIED’ INDEPENDENT REPORT ON PHARMAC

May 11, 2022,

Dr Ken Romeril, of Wellington, receives his MNZM for services to haematology.

May 4, 2022,

Updates on the Rapidly Changing Therapeutic Landscape in Multiple Myeloma

May 1, 2022,

Multiple Myeloma Media Release

April 28, 2022,

Decision on access criteria for oral COVID-19 treatments

April 24, 2022,

FRAIL-M TRIALS FOR TRANSPLANT INELIGIBLE MYELOMA (PHASE I/II)

April 19, 2022, ,

Honoured haematologist and HIV pioneer fears he won’t see action from ‘glacial’ Pharmac in his lifetime.

April 10, 2022,

COVID-19 information for patients and whānau with cancer.

March 25, 2022,

Pharmac Review Final Report – Update

March 10, 2022

Newsletter: Autumn 2022

March 6, 2022

Endorsers of the ICBCC Patient Impact Statement

March 3, 2022, ,

Myeloma Australia’s Medical and Scientific Advisory Group (MSAG), article of the week 

February 17, 2022,

CD38 directed therapy shows promise in Multiple Myeloma

February 16, 2022

Australians have limited awareness of blood cancers, – new survey

February 11, 2022,

Which haematology patients are at higher risk of COVID-19?

February 10, 2022, ,

Expert advice on preventing infection in multiple myeloma

February 9, 2022

Dr Ken Romeril – The Medicine Gap

November 29, 2021

Newsletter: Spring 2021

November 29, 2021

Seminar: Treatment of newly diagnosed myeloma – when things don’t go to plan

November 22, 2021

Myeloma NZ End of Year Function

November 22, 2021,

COVID mortality rate a concern in vaccinated blood cancer patients

November 17, 2021,

Proactive fatigue screening and management called for in blood cancer patients

November 10, 2021

Covid-19: ‘Not fair’ unvaccinated will force mum with blood cancer to stay ‘locked’ in home for remaining years

October 29, 2021, ,

New Trial In Relapsed/refractory multiple myeloma

October 28, 2021

Paediatric oncology parents are pleased with quality of care despite pandemic

October 21, 2021, ,

PVd triplet therapy now on PBS for MM patients after first relapse

October 13, 2021,

ATAGI specifies which patients with haematological malignancy should have COVID-19 booster vax

October 13, 2021, ,

‘I am screwed if it comes back’: Experts concerned by Covid’s hidden impact on blood cancer treatments

September 27, 2021, ,

Myeloma Research Review – Issue 39

September 2, 2021,

Newsletter: Winter 2021

August 16, 2021,

CANCELLED: National Patient Seminar – 13 November 2021

August 8, 2021,

Distress doubles for blood cancer patients during pandemic

July 18, 2021, ,

Distress doubles for blood cancer patients during pandemic

July 14, 2021,

Isatuximab another string in the bow for management of RRMM

June 22, 2021,

Wellington Patient Meeting 1 July

June 15, 2021,

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

June 9, 2021,

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

June 9, 2021,

Donna’s Advice to Multiple Myeloma Patients

June 9, 2021,

Haematologist slams ‘treatment lottery’ for amyloidosis patients

June 9, 2021

When the new normal is far from normal. Jason Oxenham on combatting cancer

June 1, 2021,

PBAC blocks access to new myeloma drugs: Prof Andrew Spencer

May 18, 2021,

What are the stages of multiple myeloma?

May 3, 2021,

Novel Experimental Drugs for Treatment of Multiple Myeloma

May 3, 2021,

Auckland Myeloma Patient Seminar

April 15, 2021,

Updates from Recent Clinical Trials in Multiple Myeloma

April 9, 2021,

Australian myeloma registry highlights challenges of adhering to best practice

April 3, 2021,

Article of the week

March 28, 2021,